8 month16 on the same day, Guo Qiang, deputy general manager of Wuhan company of national pharmaceutical engineering, and his party led a team to Xinda biological (Hangzhou) co., ltd.3000KG antibody Products Project

Construction site, on-site service and design visits. At present, the whole construction site has entered a series of commissioning and finishing work such as pipeline installation and commissioning, process equipment commissioning, clean air pressure commissioning, etc. Guo Qiang and his party listened carefully to the feedback of the owners on the site, carefully made records of on-site return visits, cooperated with the construction party to solve the actual problems on the site, and set an example for the smooth completion of Cinda Biology (Hangzhou) project with a attentive and professional attitude.

Xinda Biological (Hangzhou) Co., Ltd. thanked the Sinoparmaceutical engineering design team for their strong support during the construction service process, and awarded Sinoparmaceutical Engineering the banner of "exquisite design, rich experience, thoughtful service, and professionalism.

The imminent completion of the project marks a milestone in the field of large-scale antibody engineering construction in China, coinciding with the launch of another tolecizumab injection (trade name: Xinbile) from Cinda Bio (Hangzhou), which is a pro-protein converting enzyme subtilysin.9( PCSK9) inhibitors, providing a new therapeutic idea for clinical lipid-lowering therapy. The National Medicine Project will adhere to technology as the core, with a dedicated attitude and professional services, give full play to technical advantages and regional coordination, and continue to make efforts to provide high-quality and excellent technical services for the development of medicine and health.

(Wuhan Business Department Office)